企業プロフィール
Coya Therapeutics 株価・ニュース・カタリスト
- ティッカー:
- COYA
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
4.96 USD (+1.85%)
終値
最終更新: 2026年8月24日
111M USD
時価総額
株価変動の要因
As of Aug 24, 2026, COYA closed up 1.85% at $4.96. No new same-company headline was identified in the current news window.
企業概要
事業概要
Coya Therapeutics is a biotechnology company focused on immunomodulation and neurodegenerative disease, especially ALS and related conditions. Its story centers on modulating immune pathways to potentially slow neurodegeneration.
所在地とセクター分類
Coya is headquartered in the United States and listed on NASDAQ. It sits in neuroscience and immunology biotechnology.
ビジネスモデルの特徴
The company depends on clinical data, translational validation, and capital support while developing a narrow pipeline. Investors watch early efficacy signals and whether the biology can support a differentiated CNS thesis.
バイオ業界での位置付け
Coya occupies a specialized immunology-neuroscience niche within biotech. The stock is catalyst-sensitive because it is still proving whether the platform can matter in neurodegeneration.
今後のカタリスト
- Coya’s catalysts are its immunomodulation and neuroinflammation programs, where the next clinical update can change how investors view the company. The company remains early and data-dependent.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。